CNBX Pharmaceuticals Inc. (CNBX)
OTCMKTS · Delayed Price · Currency is USD
0.0004
+0.0001 (14.29%)
Aug 18, 2025, 2:31 PM EDT
CNBX Pharmaceuticals Revenue
In the fiscal year ending August 31, 2024, CNBX Pharmaceuticals had annual revenue of $130.07K, down -68.29%.
Revenue
130.07K
Revenue Growth
-68.29%
P/S Ratio
n/a
Revenue / Employee
n/a
Employees
2
Market Cap
123.27K
Revenue Chart
Revenue History
Fiscal Year End | Revenue | Change | Growth |
---|---|---|---|
Aug 31, 2024 | 130.07K | -280.09K | -68.29% |
Aug 31, 2023 | 410.17K | 380.21K | 1,269.13% |
Aug 31, 2022 | 29.96K | - | - |
Aug 31, 2021 | - | - | - |
Aug 31, 2020 | 7.16K | -2.69K | -27.29% |
Aug 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Aug 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Aug 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Aug 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Aug 31, 2015 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
Company Name | Revenue |
---|---|
Veradigm | 588.02M |
Tian'an Technology Group | 1.78M |
Elite Pharmaceuticals | 105.45M |
Glass House Brands | 221.55M |
American Oncology Network | 1.76B |
Northwest Biotherapeutics | 1.09M |
Silence Therapeutics | 27.17M |
Longduoduo Company | 4.99M |
CNBX Pharmaceuticals News
- 2 years ago - Cannabis REITs: Smoked Out - Seeking Alpha
- 3 years ago - CNBX to Enter the Cancer Immunotherapy Market After Acquiring a Controlling Interest in TaGeza Biopharma - PRNewsWire
- 3 years ago - CNBX Files New PCT Patent Application For Cannabinoids-Based Neoadjuvant Cancer Therapy - PRNewsWire
- 3 years ago - CNBX Patent Application "Composition and Method for Treating Cancer with Cannabinoids" Enters National Phase in US and Israel - PRNewsWire
- 3 years ago - CNBX Peer-reviewed Study: "Possible Future Therapeutic Value" for CNBX Proprietary Drug Candidate - PRNewsWire
- 3 years ago - CNBX Pharmaceuticals Announces New Patent Granted in Australia - PRNewsWire
- 3 years ago - CNBX Pharmaceuticals Granted Patent in Hong Kong - PRNewsWire
- 3 years ago - Cannabics Pharmaceuticals Changes Name to CNBX Pharmaceuticals - PRNewsWire